FY19 bulk funding order for grifols (prolastin) for the boise, ID VAMC.
Ended Awarded Last action
- Contract number
- 36C26019N0058
- Awardee
-
Grifols Therapeutics LLC UEI UFQ3A7GKJ5C7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $193,788
Award facts
- Contract value 100% obligated
- $193,787.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$14,212 | |
| Original award | $208,000 |
About this award
This is a Fiscal Year 2019 bulk funding order for Prolastin, a pharmaceutical product, awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a Blanket Purchase Agreement (BPA) call against the Pharmaceuticals and Drugs GSA Schedule. The contract has a potential value of $193,787.52 and a completion date of September 30, 2019. No small business set-aside was used for this award. Grifols Therapeutics LLC has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and immune globulin to the VA and the Defense Logistics Agency through various contract vehicles.
Quick answers
Who was awarded contract 36C26019N0058?
36C26019N0058 was awarded to Grifols Therapeutics LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 2, 2018.
How much is contract 36C26019N0058 worth?
The government has obligated $193,788 on 36C26019N0058.
Is contract 36C26019N0058 an order under another contract?
Yes. 36C26019N0058 is a BPA call under V797D30042-36E79718A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26019N0058 competed?
The extent of competition for 36C26019N0058 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award